HALO logo
halo search icon
Filana Therapeutics, Inc.
Filana Therapeutics, Inc.
FLNA · NAS

Filana Therapeutics, Inc.

US$1.25

Price Arrow0.05 (4.17%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusHALO All
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Filana Therapeutics, Inc. Overview

FLNA Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Strong

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About FLNA

icon

Telephone

1.512.501.2444

icon

Address

Suite 300, 6801 North Capital of Texas Highway, Austin, TX 78731

Description

Filana Therapeutics, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.

FLNA Price Chart

Key Stats

Market Cap

US$57.97M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.16 - 4.98

Trade Value (12mth)

US$884,111.00

1 week

1.69%

1 month

-29.41%

YTD

-42.58%

1 year

-41.46%

All time high

146.16

Key Fundamentals

EPS 3 yr Growth

-0.70%

EBITDA Margin

0.00%

Operating Cashflow

-$32m

Free Cash Flow Return

-29.30%

ROIC

-82.70%

Interest Coverage

0.00

Quick Ratio

2.20

Other Data

Shares Outstanding (Fully Diluted)

48m

HALO Sector

Healthcare

Next Company Report Date

02-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

FLNA Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-2.32-0.53-1.88locklocklock
EPS (Fully Diluted)
$locklocklocklock-2.32-1.46-1.88locklocklock
Growth
%locklocklocklock-22.277.3-258.5locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Filana Therapeutics, Inc. (FLNA:NAS)?
Halo FAQ
The current share price of Filana Therapeutics, Inc. (FLNA:NAS) is USD$1.25.
What is the 52-week high share price for Filana Therapeutics, Inc. (FLNA:NAS)?
Halo FAQ
The 52-week high share price for Filana Therapeutics, Inc. (FLNA:NAS) is USD$4.98.
What is the 52-week low share price for Filana Therapeutics, Inc. (FLNA:NAS)?
Halo FAQ
The 52-week low share price for Filana Therapeutics, Inc. (FLNA:NAS) is USD$1.16.
What is the dividend yield for Filana Therapeutics, Inc. (FLNA:NAS)?
Halo FAQ
Filana Therapeutics, Inc. (FLNA:NAS) does not pay a dividend.
What was Filana Therapeutics, Inc. (FLNA:NAS) last dividend payment?
Halo FAQ
The last dividend payment of Filana Therapeutics, Inc. (FLNA:NAS) is USD$0.75.
What is the franking level for Filana Therapeutics, Inc. (FLNA:NAS)?
Halo FAQ
Filana Therapeutics, Inc. (FLNA:NAS) has a franking level of 0.00%.
In which sector is Filana Therapeutics, Inc. (FLNA:NAS) classified?
Halo FAQ
Filana Therapeutics, Inc. (FLNA:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.